Share
2,970 Posts.
lightbulb Created with Sketch. 576
clock Created with Sketch. 28/03/25
11:06
Share
Originally posted by logan123:
↑
As predicted, Prof Miles Prince is on track with getting underway in regard to the Clinical Sites for the PTX100 Phase 2a study. l am also very excited about the new CMO Dr Marissa Lim she has a wealth of experience and it is impeccable timing for her to be on board, it appears that James Mc Donnell and the board are forming a strong team to move forward. Also l am pleased that Epworth Freemasons are handling the first Clinical Trial as their Haematology Unit is one of the best in Australia, and l am keen to see the results from the USA and Europe's Clinicals Study. l hope many lives are saved by this amazing treatment and secondly l hope that genuine shareholders are rewarded in time.
Expand
Great post. I'm a bit surprised the market hasn't moved on the developments this week. Finally, the wheels are turning.
(20min delay)